Carlsmed, Inc. Increase (Decrease) in Accounts Receivable
Carlsmed, Inc. (CARL) reported Increase (Decrease) in Accounts Receivable of $3.55 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- Carlsmed, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $2.25M, a 19.66% increase year-over-year.
- Carlsmed, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $1.31M, a 6.90% decline year-over-year.
- Carlsmed, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $117.00K, a 92.64% decline year-over-year.
- Carlsmed, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $1.61M, a 1543.88% increase year-over-year.
- Carlsmed, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $5.01M, a 26.23% increase from fiscal 2024.
- Carlsmed, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $3.97M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.55M 10-Q · filed 2026-08-05 | $3.67M derived: sum of 3 quarters · filed 2026-08-05 | $5.28M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.31M 10-Q · filed 2026-05-05 | $1.43M derived: sum of 2 quarters · filed 2026-05-05 | $3.04M derived: sum of 3 quarters · filed 2026-05-05 | $4.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.73M derived: sum of 2 quarters · filed 2026-02-25 | $3.60M derived: sum of 3 quarters · filed 2026-08-05 | $5.01M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.49M derived: sum of 2 quarters · filed 2026-08-05 | $4.89M 10-Q · filed 2025-11-06 | $6.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.28M 10-Q · filed 2026-08-05 | $4.87M derived: sum of 3 quarters · filed 2026-08-05 | $4.97M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.41M 10-Q · filed 2026-05-05 | $3.00M derived: sum of 2 quarters · filed 2026-05-05 | $3.09M derived: sum of 3 quarters · filed 2026-05-05 | |
| 2024-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.69M derived: sum of 2 quarters · filed 2026-02-25 | $3.97M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.38M 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $2.28M 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |